# Outcome of Different IOLs in Patients With and Without Uveitis

> **NCT02975895** · NA · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 56 (actual)

## Conditions studied

- Uveitis
- Cataract
- Inflammation
- Posterior Capsule Opacification

## Interventions

- **DEVICE:** Hydrophobic IOL: Vivinex (HOYA)
- **DEVICE:** Hydrophilic IOL: INCISE (Bausch+Lomb)

## Key facts

- **NCT ID:** NCT02975895
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-30
- **Primary completion:** 2021-02-22
- **Final completion:** 2022-03-17
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02975895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02975895, "Outcome of Different IOLs in Patients With and Without Uveitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02975895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*